Association for Accessible Medicines
FDANonrulemakingFDA-2017-N-3615

Administering the Hatch-Waxman Amendments: Ensuring an Appropriate Balance Between Innovation and Access

RIN
Last modified
Aug 12, 2022
Comment window
closed 3175d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Nov 20, 2017 and Nov 20, 2017. 24 other organizations filed here. The comment window closed 3175d ago.

What Association for Accessible Medicines filed (1)

Nov 20, 2017· Comment from Association for Accessible Medicines· FDA-2017-N-3615-0097

The Association for Accessible Medicines (AAM) is pleased to provide comments to the Food and Drug Administration (FDA or the Agency) in response to the Agency's Federal Register Notice entitled "Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access; Public Meeting; Request for Comments."

Abstract

OPEN

View on regulations.gov →
Administering the Hatch-Waxman Amendments: Ensuring an Appropriate Balance Between Innovation and Access (FDA) — Association for Accessible Medicines | OpenPolis